People · Operator
Named in public records as an officer, director or promoter · active 2008–2021 · Other, Biotech / Pharma, Other Health Care, Pharmaceuticals, Other Technology, Computers
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DigitalOcean Holdings, Inc. | — | Other | Series C | $208.5M | $474.6M | 2020 |
| TwinStrand Biosciences, Inc. | — | Biotech / Pharma | Series C | $85.0M | $132.4M | 2017 |
| Arterys Inc | — | Other Health Care | Series B | $61.6M | $540.3M | 2015 |
| Limerick Biopharma Inc | — | Pharmaceuticals | Series B | $52.8M | $16.3M | 2010 |
| Rubicon Markets Inc. | — | Other Technology | Series A | $10.7M | $296.2M | 2018 |
| Plectix Biosystems Inc | — | Computers | Series A | $6.9M | $229.8M | 2008 |
| Kabira Technologies Inc | — | Computers | Seed | $2.0M | $81.6M | 2009 |
Steve Dow at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steve Dow on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chad Waite | 3 | 11 |
| Kristina Burow | 1 | 16 |
| Corey Goodman | 1 | 13 |
| Peter Levine | 1 | 11 |
| Brad Gillespie | 1 | 10 |
| Karl Alomar | 1 | 8 |
| Scott Minick | 1 | 7 |
| David Rosa | 1 | 5 |
| Jason Seats | 1 | 5 |
| Warren Adelman | 1 | 5 |
| Soma Somasegar | 1 | 5 |
| Stephen Dow | 1 | 4 |
| Robert Brownell | 1 | 4 |
| Corey S. Goodman | 1 | 4 |
| Michael Pellini | 1 | 4 |
| Jason Myers | 1 | 4 |
| Christopher Benoit | 1 | 3 |
| Jesse Salk | 1 | 3 |
| Jeanne Bayless | 1 | 3 |
| Wendye Robbins | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.